Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: The Effects of Platelet Rich Plasma Adjuvant to Type I/III Collagen Ratio, Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Pelvic Organ Prolapse Repair [NA]

View source ↗

Summary

An ongoing clinical trial at Andalas University evaluating platelet-rich plasma as an adjuvant to Type I/III collagen in pelvic organ prolapse repair; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (platelet-rich plasma)
  • Type I/III collagen (Type I/III collagen)

Snippet

Sponsor: Andalas University | Conditions: Pelvic Organ Prolapse Vaginal Surgery, Platelet Rich Plasma Injection | NA | Status: RECRUITING